More Than Half Industry Sectors in Correction, S&P Outlook
March’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
Find various ways to profit from your skills and maximize your earning potential. Start turning your abilities into cash now!
17,603 articlesMarch’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Could one token rise to seven figures in the next decade? This article explores the idea, the logic behind it, and a ...
AI-driven forecasts for XRP and Solana diverge by end-2026, leaving investors weighing who could win. The analysis us...
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...
A New York rally billed as a discussion on the economy devolved into tangents about toiletries and voter rules, under...
Georgia announces a government-backed stablecoin project with Tether, aiming to modernize payments, cut costs, and bo...
Frontline loan teams report AI fatigue but are finding practical paths forward. This article outlines simple, actiona...
Accenture stands out as a strong contender in the consulting arena. This article digs into why investors should pay a...